Addressing the toughest GLP-1 agonist formulation challenges with excipients

WEBINAR

In this webinar, you will learn:

• Highlighting the critical role of excipients in formulating GLP-1 agonists for liquid and solid dosage forms
• Designing effective dosage forms, emphasizing solid formulations for solubility enhancement and targeted drug release using a carrier-based excipient
• Insights on granulated buffers in liquid formulations and future perspectives in GLP-1 development

In our upcoming webinar, we will discuss the vital role of excipients in formulating GLP-1 agonists in both liquid and solid forms. We will cover the historical significance and therapeutic potential of GLP-1 agonists for diabetes and obesity, along with formulation challenges for injectables and oral solids. Key topics include excipients that enhance solubility, direct compression, and results using a carrier excipient for targeted drug release of a GLP-1 agonist in the intestine. We will also explore the benefits of granulated buffers in liquid formulations for efficient drug preparation. This session focuses on enhancing the understanding of excipients in pharmaceutical development. It is designed for formulation scientists and professionals in GLP-1 therapy design.

As part of a series, this session will focus on the formulation foundations while the upcoming session will highlight the use of various formulation strategies enabling GLP-1 agonist delivery via excipients.